Changing Lives Through Research

On the Job
With more than 25 combined years of
experience, Dominique Vicchairelli and
Milagros “Milly” Yax have made helping
others the focus of their careers. Before
joining the Department of Surgery, Yax
worked as a medical assistant, most recently
with Jefferson Internal Medicine in Voorhees,
NJ. Since becoming Clinical Coordinator
in Surgery last November, she no longer
checks patients’ vitals or assists physicians
with exams – but she’s found a new way
to make a difference. Yax is responsible for
assisting patients of Harish Lavu, MD, FACS,
and Jordan M. Winter, MD, FACS, who both
specialize in pancreatic cancer surgery.

Clinical Research Team members Rupa Chowdary, Matthew Isenberg, MSW, Jamie Jay Rothstein, RN, CCRC,
CCRP, Subikram “Raaj” Chandra, Karishma Kurowski, MPH, Kyle Peer, and Dee Rinaldi manage the administrative
and regulatory aspects of all clinical trials in the Department of Surgery.

Clinical Research Team
Supports Over 100 Diverse,
Complex Trials
Faculty in the Department of
Surgery are currently leading or
participating in more than 100
clinical trials. Each has a distinct
protocol and requires management
of numerous components – from
patient recruitment and informed
consent to electronic data entry
and management of subject
care throughout the trial. All of
these activities must comply with
regulations imposed by the Food &
Drug Administration (FDA), National
Institute of Health (NIH) Collaborative
Institutional Training Initiative (CITI)
and Health Insurance Portability and
Accountability Act (HIPAA), which
require the protection of Personal
Health Information.

Since 2009 Vicchairelli has provided the same
service for the patients of Charles J. Yeo, MD,
FACS, the Samuel D. Gross Professor and Chair
of Surgery and Co-Director of the Jefferson
Pancreas, Biliary and Related Cancer Center.
As Clinical Coordinators, they each serve as
their patients’ primary point of contact –
from scheduling the initial appointment
and navigating diagnostic tests and referrals
through treatment and follow-up.
“I enjoy taking care of our patients from
beginning to end,” Yax says. “They get to
know me, and we build a relationship. They
know they can come to me with questions or
concerns. I think it makes a huge difference
for them to have my email address and direct
phone number versus talking to someone
different every time they call. It’s much more
personalized.”

“As just one example, we’re
supporting Dr. Adam Berger with a
Phase 2 international multi-center
trial of a compound that could
function as a personalized vaccine
therapy for melanoma patients,”
Rothstein says. The team is working
with Dr. Berger on nine other trials,
including the INTEGRATE study,
which is following patients with
cutaneous melanoma who have had
the DecisionDx-Melanoma gene
expression assay performed.

In addition, Vicchairelli provides
administrative support for the Jefferson
Pancreas Tumor Registry (JPTR), which
collects information from pancreatic cancer

Additionally, the team is coordinating
with Dr. Melissa Lazar on a clinical
trial for patients diagnosed with breast
cancer. The goal: to determine if
standard of care lumpectomy (SOC)

or SOC lumpectomy along with use
of a MarginProbe® device offers
greater safety and effectiveness. The
device is designed to help surgeons
quickly achieve “clean margins” by
identifying cancerous (malignant)
tissue in the surrounding tissue of
the tumor in real time, rather than
waiting for an assessment from the
pathologist.

patients and family members who enroll in
the study. The registry, established in 2008,
now has well over 500 people enrolled: 65%
have sporadic (non-hereditary pancreatic)
cancers, 14% have familial (hereditary)
pancreatic cancers, 14% are non-affected
family members and 7% have closely related
conditions. All registrants are asked to
complete an extensive questionnaire. The
Registry is directed by Theresa P. Yeo, PhD,
and Harish Lavu, MD.
“I know it’s a lot of paperwork, but it’s so
important for our patients and their families
to complete it,” Vicchairelli says. “The data
is invaluable in helping us study the disease,
so we can understand not only the genetic
components but also potential environmental
and occupational risk factors.”
For more information about the JPTR or
to download questionnaires, please visit
Jefferson.edu/Pancreasregistry

Meet the Team
Rothstein’s team now includes six
Clinical Research Coordinators (CRCs)
and a Clinical Research Specialist.
Matthew Isenberg, MSW, CRC II,
joined the team in 2013. He identified,
screened, interviewed and recruited
eligible patients for the Department’s

“Management of the protocol can play a critical role in a
clinical trial’s success or failure,” Rothstein says. “I am proud
of the talented team that we have assembled to support the
Department’s robust and expanding clinical trial program.”
To navigate those complexities, the
Department relies on the Clinical
Research Team, led by Jamie Jay
Rothstein, RN, CCRC, CCRP. The team
is supporting a wide variety of clinical
trials that are open and accruing
patients in the following specialties:
bariatric, cardiothoracic, colorectal,
pancreatic, transplant, trauma and
vascular surgery.
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highest-accruing trial studying a
pancreatic cancer vaccine from
NewLink Genetics. He is now the lead
coordinator on this trial.
Karishma Kurowski, MPH, CRC II,
joined the team in 2014. She is skilled
in navigating protocols, collecting
data, and obtaining informed consent,
including educating subjects about
clinical protocols, required therapies

and procedures, and answering
subject questions.
Rupa Chowdary and Subikram “Raaj”
Chandra are each lead CRCs for their
own trials and are responsible for
many activities – from preparing for
subject visits and completing source
documentation to entering data into
the Electronic Data Capture system
promptly after each visit. Another key
responsibility: the time-consuming
task of reporting adverse events (AEs)
and serious adverse events (SAEs) per
FDA guidelines.
Other members of the team include
Kyle Peer, who joined last year as a
Clinical Research Specialist and Dee
Rinaldi, CRC II, who joined the team
in April.
“Management of the protocol can
play a critical role in a clinical trial’s
success or failure,” Rothstein says. “I
am proud of the talented team that
we have assembled to support the
Department’s robust and expanding
clinical trial program.”
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